The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2004
DOI: 10.1016/j.ophtha.2003.09.043
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphic corneal amyloidosis*1A disorder due to a novel mutation in the Transforming Growth Factor ??Induced (BIGH3) gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0

Year Published

2005
2005
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 12 publications
0
22
0
Order By: Relevance
“…Based on the knowledge of the molecular genetics of the corneal dystrophies their diagnosis should now be determined by the molecular genetic results [1][2][3][4][5][6][7][8][12][13][14][15][16][17][18][19][20][21][22][23][24].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on the knowledge of the molecular genetics of the corneal dystrophies their diagnosis should now be determined by the molecular genetic results [1][2][3][4][5][6][7][8][12][13][14][15][16][17][18][19][20][21][22][23][24].…”
Section: Discussionmentioning
confidence: 99%
“…In some patients with CDBII, linkage analysis revealed the underlying molecular genetic defect at chromosome 10q24, which involves an as yet-unknown gene. In addition to these mutations, mutational heterogeneity exists and screening of the TGFBI gene has identified a number of unique coding region mutations [19][20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…Eifrig et al [2004a] documented a form of autosomal dominant corneal amyloidosis that manifested primarily as polymorphic stromal opacities. This disorder was designated primary polymorphic amyloidosis and affected individuals carried a c.1637C4A (Ala546Asp) mutation in TGFBI.…”
Section: Autosomal Dominant Stromal Amyloidosesmentioning
confidence: 99%
“…Increasing numbers of rare gene mutations, such as L518P (Endo et al 1999;Hirano et al 2000), L527R (Fujiki et al 1998Hirano et al 2001), A546D (Aldave et al 2004a;Eifrig et al 2004;Klintworth et al 2004), P551Q (Aldave et al 2004b;Klintworth et al 2004), L569R (Warren et al 2003), or H626R (Afshari et al 2001;Chau et al 2003;Dighiero et al 2001;Ellies et al 2002), have recently been reported and identified as being associated with mutations in the TGFBI gene. These findings indicate that a broader spectrum of disease phenotypes for CDs probably exists than previously believed.…”
Section: Discussionmentioning
confidence: 99%